|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02179 RECBIO-B
Nominal 
4.620 0.000 (0.000%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 12,726 | -- | 0 | 0 | 0 | 0 |
| Cost of Sales | (1,492) | -- | -- | -- | -- | -- |
| Gross Profit | 11,234 | -- | -- | -- | -- | -- |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (608,230) | 8.246% | (561,897) | (572,443) | (735,996) | (657,566) | |
| Taxation | (2,160) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | (492) | 486 | 13,293 | 5 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (610,390) | 8.535% | (562,389) | (571,957) | (722,703) | (657,561) | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 21,152 | -- | (2,481) | (32,014) | (20,441) | 45,953 |
| Depreciation & Amortisation | 125,308 | 44.960% | 86,443 | 66,378 | 44,335 | 22,458 |
| Directors' Emoluments | -- | -- | 26,168 | 34,553 | 28,937 | 97,500 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -115.000 | -0.862% | -116.000 | -119.000 | -152.000 | -156.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.971) | (1.327) | (1.222) | (1.122) |
| NBV per share ($) | 1.127 | -- | 1.096 | 2.218 | 3.441 | -- |
| Remarks: | Real time quote last updated: 26/03/2026 07:55 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -610,390 |
| %Change | 8.535% |
| EPS / (LPS) | RMB -1.150 |
| NBV Per Share (¥) | RMB 1.127 |